How to buy Precision BioSciences stock | $9.65

Precision BioSciences Inc is a biotechnology business based in the US. Precision BioSciences shares (DTIL) are listed on the NASDAQ and all prices are listed in US Dollars. Precision BioSciences employs 236 staff and has a trailing 12-month revenue of around 0.00.

Precision BioSciences stock price (NASDAQ: DTIL)

Use our graph to track the performance of DTIL stocks over time.

Precision BioSciences shares at a glance

• Key figures

Information last updated 2021-10-17.

Latest market close	$9.65
52-week range	$6.04 - $16.60
50-day moving average	$11.98
200-day moving average	$10.65
Wall St. target price	$18.56
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.85

Buy Precision BioSciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Precision BioSciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Precision BioSciences price performance over time

Historical closes compared with the close of $9.65 from 2021-10-22

1 week (2021-10-15)	-1.43%
1 month (2021-09-24)	-23.59%
3 months (2021-07-23)	-5.85%
6 months (2021-04-23)	4.55%

1 year (2020-10-23)	38.25%
2 years (2019-10-23)	50.78%
3 years (2018-10-20)	N/A
5 years (2016-10-20)	N/A

Precision BioSciences financials

Revenue TTM	$101.4 million
Gross profit TTM	$24.3 million
Return on assets TTM	-14.07%
Return on equity TTM	-49.96%
Profit margin	-45.88%
Book value	$1.70
Market capitalisation	$583.3 million

TTM: trailing 12 months

Shorting Precision BioSciences shares

There are currently 2.4 million Precision BioSciences shares held short by investors – that's known as Precision BioSciences's "short interest". This figure is 7.6% down from 2.6 million last month.

There are a few different ways that this level of interest in shorting Precision BioSciences shares can be evaluated.

Precision BioSciences's "short interest ratio" (SIR)

Precision BioSciences's "short interest ratio" (SIR) is the quantity of Precision BioSciences shares currently shorted divided by the average quantity of Precision BioSciences shares traded daily (recently around 470531.88976378). Precision BioSciences's SIR currently stands at 5.08. In other words for every 100,000 Precision BioSciences shares traded daily on the market, roughly 5080 shares are currently held short.

However Precision BioSciences's short interest can also be evaluated against the total number of Precision BioSciences shares, or, against the total number of tradable Precision BioSciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Precision BioSciences's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Precision BioSciences shares in existence, roughly 40 shares are currently held short) or 0.0483% of the tradable shares (for every 100,000 tradable Precision BioSciences shares, roughly 48 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Precision BioSciences.

Find out more about how you can short Precision BioSciences stock.

Precision BioSciences share dividends

We're not expecting Precision BioSciences to pay a dividend over the next 12 months.

Precision BioSciences share price volatility

Over the last 12 months, Precision BioSciences's shares have ranged in value from as little as $6.04 up to $16.6. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precision BioSciences's is 1.7152. This would suggest that Precision BioSciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Precision BioSciences overview

Precision BioSciences, Inc. , a genome editing company, develops therapeutic products in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene correction activities. This segment develops PBCAR0191, which is in Phase 1/2a clinical trial, an allogeneic anti-CD19 CAR T cell product candidate for the patients with relapsed or refractory, or R/R, non-Hodgkin lymphoma, or NHL, or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; and PBCAR20A, that is in Phase 1/2a clinical trial, an allogeneic anti-CD20 CAR T therapy for the treatment NHL, chronic lymphocytic leukemia, and small lymphocytic lymphoma, as well as developing PBCAR269A, which is in Phase 1/2a clinical trial, an allogeneic anti-BCMA CAR T cell product candidate for the treatment of R/R multiple myeloma. The Food segment develops food and nutrition products; and provides technology-centric solutions, Elo life systems, and Elo's technology platform solutions.

Frequently asked questions

What percentage of Precision BioSciences is owned by insiders or institutions?
Currently 11.075% of Precision BioSciences shares are held by insiders and 56.165% by institutions. How many people work for Precision BioSciences?
Latest data suggests 236 work at Precision BioSciences. When does the fiscal year end for Precision BioSciences?
Precision BioSciences's fiscal year ends in December. Where is Precision BioSciences based?
Precision BioSciences's address is: 302 East Pettigrew Street, Durham, NC, United States, 27701 What is Precision BioSciences's ISIN number?
Precision BioSciences's international securities identification number is: US74019P1084 What is Precision BioSciences's CUSIP number?
Precision BioSciences's Committee on Uniform Securities Identification Procedures number is: 74019P108